Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells
- PMID: 9292016
- DOI: 10.1099/0022-1317-78-9-2287
Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells
Abstract
The complete nucleotide sequences of the genomes of dengue-1 virus virulent 45AZ5 PDK-O and attenuated vaccine candidate strain 45AZ5 PDK-27 have been determined and compared with the dengue-1 virus Western Pacific (West Pac) 74 parent strain from which 45AZ5 PDK-O was derived. Twenty-five (0.23%) nucleotide and 10 (0.29%) amino acid substitutions occurred between parent strain dengue-1 virus West Pac 74 and virulent strain 45AZ5 PDK-O, which was derived from the parent by serial passage in diploid foetal rhesus lung (FRhL-2) and mutagenized with 5-azacytidine. These substitutions were preserved in the 45AZ5 PDK-27 vaccine. 45AZ5 PDK-O and PDK-27 strains, which differ by 27 passages in primary dog kidney (PDK) cells, show 25 (0.23%) nucleotide and 11 (0.32%) amino acid divergences. These comparative studies suggest that the changes which occurred between the West Pac 74 and 45AZ5 PDK-O strains may alter the biological properties of the virus but may not be important for attenuation. Important nucleotide base changes responsible for attenuation accumulated between 45AZ5 PDK-O and 27.
Similar articles
-
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.J Infect Dis. 1994 Dec;170(6):1448-55. doi: 10.1093/infdis/170.6.1448. J Infect Dis. 1994. PMID: 7995984 Clinical Trial.
-
Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate.Vaccine. 2010 Apr 9;28(17):3030-7. doi: 10.1016/j.vaccine.2009.10.084. Epub 2009 Oct 27. Vaccine. 2010. PMID: 19874927
-
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.Virology. 1997 Apr 14;230(2):300-8. doi: 10.1006/viro.1997.8500. Virology. 1997. PMID: 9143286
-
Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command.Am J Trop Med Hyg. 2003 Dec;69(6 Suppl):1-4. doi: 10.4269/ajtmh.2003.69.6_suppl.0690001. Am J Trop Med Hyg. 2003. PMID: 14756126 Review. No abstract available.
-
The causes and consequences of genetic variation in dengue virus.Trends Microbiol. 2000 Feb;8(2):74-7. doi: 10.1016/s0966-842x(99)01669-8. Trends Microbiol. 2000. PMID: 10664600 Review.
Cited by
-
Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain.Virus Genes. 2000;20(1):57-63. doi: 10.1023/a:1008160123754. Virus Genes. 2000. PMID: 10766307
-
Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence.J Virol. 1998 Feb;72(2):1647-51. doi: 10.1128/JVI.72.2.1647-1651.1998. J Virol. 1998. PMID: 9445071 Free PMC article.
-
Complete nucleotide sequence analysis of a Western Pacific dengue-1 virus strain.Virus Genes. 1998;17(1):85-8. doi: 10.1023/a:1008009202695. Virus Genes. 1998. PMID: 9778791
-
Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.J Virol. 2003 Mar;77(6):3655-68. doi: 10.1128/jvi.77.6.3655-3668.2003. J Virol. 2003. PMID: 12610141 Free PMC article.
-
Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.Virus Res. 2013 Sep;176(1-2):69-77. doi: 10.1016/j.virusres.2013.04.017. Epub 2013 May 22. Virus Res. 2013. PMID: 23707399 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases